Return to homepagePandemic Pact

Antibody-based therapies against infectious diseases

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA271297

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023
    2027

  • Known Financial Commitments (USD)

    $1,560,460.72

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    The Walter and Eliza Hall Institute of Medical Research

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Infectious diseases have resulted in devastating mortality in human populations throughout history. Antibody-based therapies have revolutionised modern medicine and will be important for the prevention and treatment of diseases caused by some of the world’s deadliest pathogens. Our program builds on a deep understanding of the molecular interactions between human and pathogen and leverages advanced antibody platforms to develop novel antibody therapies against malaria and COVID-19.